Wednesday January 31, 2024
3:00 PM – 4:00 PM UTC / 4:00 PM – 5:00 PM CET / 10:00 AM – 11:00 AM EST
Agenda:
- Introduction – Prof Florian Scotté
- Overview of the Guidelines, followed by the cost-effectiveness of G-CSF and the role of biosimilars – Prof Bernardo Rapoport
- Case Review: Discussing the approach and decision to use G-CSF prophylaxis efficacy, safety, potential side effects
– Case 1 presented by Dr Nicole Kuderer
– Case 2 presented by Prof Alexandre Chan - Panel Discussion and Q&A
Learning Objectives:
- To provide an overview of neutropenia guidelines and cost effectiveness of using G-CSF
- To improve the understanding of clinicians in identifying when a patient might be eligible for G-CSF prophylaxis and when to treat in taking a shared decision approach
- The patient experience of G-CSF prophylaxis and how it impacts quality of life, adherence, and disease outcomes
- Identify strategies to optimally manage side effects of G-CSF prophylaxis and related toxicities in patients with febrile neutropenia
This webinar is made possible by sponsorship provided by Sandoz
![Sandoz logo](https://mascc.org/wp-content/uploads/2023/12/Sandoz-Logo-150x20.png)
Speakers:
![Florian Scotte](https://mascc.org/wp-content/uploads/2022/05/scotte_2022.jpg)
Prof Florian Scotté
Session Chair
![Bernardo Rapoport](https://mascc.org/wp-content/uploads/2022/05/rapoport_2022.jpg)
Prof Bernardo Rapoport
![Nicole Kuderer](https://mascc.org/wp-content/uploads/2023/12/Nicole-kuderer-450x450-1.jpg)
Dr Nicole Kuderer
![](https://mascc.org/wp-content/uploads/2023/12/alex-chan-450x450-1.jpg)
Prof Alexandre Chan